# OnCo record gracell-biotechnologies (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gracell-biotechnologies/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gracell-biotechnologies" ;
  schema:name "Gracell Biotechnologies"@en ;
  schema:alternateName "Gracell"@en, "亘喆生物"@en, "NASDAQ:GRCL"@en ;
  schema:description "Gracell Biotechnologies is the Chinese cell-therapy company that made CAR-T cells overnight with its FasTCAR process and built the BCMA and CD19 dual-targeting CAR-T GC012F, bought by AstraZeneca in 2024."@en ;
  schema:url <https://onco.cc/companies/gracell-biotechnologies/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/gc012f/> .